Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01353547 · ClinicalTrials.gov registry record

Genes and Environment in Multiple Sclerosis

A clinical trial of Multiple Sclerosis, sponsored by Columbia University.

Recruiting
Registry status
5,000
Enrollment target
5
Study locations

NCT01353547 is a study of Multiple Sclerosis that is actively recruiting participants, run by Columbia University. The registered enrollment target is 5,000 participants, above the 569-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (779% higher). The trial reports 5 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01353547, a study of Multiple Sclerosis, is actively recruiting participants, sponsored by Columbia University.

RECRUITING
Registry status
5,000 participants
Enrollment target
5
Study locations

Study Summary

The purpose of the research study is to identify the genetic, environmental and immune profiles that may increase a person's risk of developing multiple sclerosis (MS). While MS is not a disease caused by a single variation in genetic material (DNA), a single environmental factor, or a single malfunction in immune cells, there are genetic alterations, environmental exposures and immunologic factors that make the development of MS more likely. Obtaining information about who is at risk for MS will be beneficial in the future if the investigators can identify effective ways to prevent or slow down the progression of this disease.

Conditions Studied

Study Locations (5)

Massachusetts

  • Massachusetts General Hospital - Boston
  • Brigham and Women's Hospital - Boston

Maryland

  • National Institute of Neurological Disorders and Stroke - Bethesda

New York

  • Columbia University Irving Center - New York

Pennsylvania

  • University of Pittsburgh - Pittsburgh

Trial Details

FieldValue
Enrollment Target 5,000 participants
Start Date 2017-10-01
Est. Completion 2040-10

Sponsor

Columbia University

958 total trials

What the Registry Record Tells You About NCT01353547

The ClinicalTrials.gov registry entry for NCT01353547 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 5,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 569-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (779% higher). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 0 interventions.

NCT01353547 reports 5 study locations spanning 4 distinct geographic areas - top geographies include Massachusetts, Maryland, New York.

Frequently Asked Questions

What is clinical trial NCT01353547 about?

NCT01353547 is a clinical study titled "Genes and Environment in Multiple Sclerosis". The purpose of the research study is to identify the genetic, environmental and immune profiles that may increase a person's risk of developing multiple sclerosis (MS). While MS is not a disease caused by a single variation in genetic material (DNA), a single environmental factor, or a single malfun...

What is the current status of trial NCT01353547?

This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2017-10-01. Estimated completion is 2040-10.

What conditions does trial NCT01353547 study?

This clinical trial studies the following conditions: Multiple Sclerosis.

Who is sponsoring clinical trial NCT01353547?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01353547 being conducted?

This trial has 5 study locations across Maryland, Massachusetts, New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.